Patent ID: 11911381
Assignee: SUMITOMO PHARMA CO. LTD.
Field: Pharmaceuticals (Chemistry)
Classification: CPC A  C | IPC A  C

Claim 2:
3. The compound of claim 1, wherein the crystal form is characterized by a powder x-ray diffraction pattern having diffraction angle (20°) peaks of 5.3°±0.2°, 8.0°±0.2°, 11.2°±0.2°, 13.0°±0.2°, 13.5°±0.2°, 15.9°±0.2°, 16.4°±0.2°, 17.5°±0.2°, 17.9°±0.2°, 18.2°±0.2°, and 20.0°±0.2°.